Follow
Markus Maeurer
Markus Maeurer
Champalimaud Foundation, Lisbon Portugal and I Medical Clinical, University of Mainz, Germany
Verified email at fundacaochampalimaud.pt - Homepage
Title
Cited by
Cited by
Year
Antigen-processing machinery breakdown and tumor growth
B Seliger, MJ Maeurer, S Ferrone
Immunology today 21 (9), 455-464, 2000
6192000
Advances in tuberculosis diagnostics: the Xpert MTB/RIF assay and future prospects for a point-of-care test
SD Lawn, P Mwaba, M Bates, A Piatek, H Alexander, BJ Marais, ...
The Lancet infectious diseases 13 (4), 349-361, 2013
6042013
Reducing mortality from 2019-nCoV: host-directed therapies should be an option
A Zumla, DS Hui, EI Azhar, ZA Memish, M Maeurer
The Lancet 395 (10224), e35-e36, 2020
5682020
Single-cell landscape of immunological responses in patients with COVID-19
JY Zhang, XM Wang, X Xing, Z Xu, C Zhang, JW Song, X Fan, P Xia, ...
Nature immunology 21 (9), 1107-1118, 2020
5312020
New antituberculosis drugs, regimens, and adjunct therapies: needs, advances, and future prospects
AI Zumla, SH Gillespie, M Hoelscher, PPJ Philips, ST Cole, I Abubakar, ...
The Lancet infectious diseases 14 (4), 327-340, 2014
4172014
Tumor escape from immune recognition: lethal recurrent melanoma in a patient associated with downregulation of the peptide transporter protein TAP-1 and loss of expression of …
MJ Maeurer, SM Gollin, D Martin, W Swaney, J Bryant, C Castelli, ...
The Journal of clinical investigation 98 (7), 1633-1641, 1996
3841996
Immunological and inflammatory profiles in mild and severe cases of COVID-19
JW Song, C Zhang, X Fan, FP Meng, Z Xu, P Xia, WJ Cao, T Yang, XP Dai, ...
Nature communications 11 (1), 3410, 2020
3832020
Tuberculosis: progress and advances in development of new drugs, treatment regimens, and host-directed therapies
S Tiberi, N du Plessis, G Walzl, MJ Vjecha, M Rao, F Ntoumi, S Mfinanga, ...
The Lancet Infectious Diseases 18 (7), e183-e198, 2018
3642018
Tuberculosis comorbidity with communicable and non-communicable diseases: integrating health services and control efforts
BJ Marais, K Lönnroth, SD Lawn, GB Migliori, P Mwaba, P Glaziou, ...
The Lancet infectious diseases 13 (5), 436-448, 2013
3642013
Drug-resistant tuberculosis: time for visionary political leadership
I Abubakar, M Zignol, D Falzon, M Raviglione, L Ditiu, S Masham, I Adetifa, ...
The Lancet infectious diseases 13 (6), 529-539, 2013
3612013
TAP off—tumors on
B Seliger, MJ Maeurer, S Ferrone
Immunology today 18 (6), 292-299, 1997
3061997
Tuberculosis—advances in development of new drugs, treatment regimens, host-directed therapies, and biomarkers
RS Wallis, M Maeurer, P Mwaba, J Chakaya, R Rustomjee, GB Migliori, ...
The Lancet infectious diseases 16 (4), e34-e46, 2016
3022016
Host-directed therapies for infectious diseases: current status, recent progress, and future prospects
A Zumla, M Rao, RS Wallis, SHE Kaufmann, R Rustomjee, P Mwaba, ...
The Lancet Infectious Diseases 16 (4), e47-e63, 2016
2962016
Tuberculosis biomarkers discovery: developments, needs, and challenges
RS Wallis, P Kim, S Cole, D Hanna, BB Andrade, M Maeurer, M Schito, ...
The Lancet infectious diseases 13 (4), 362-372, 2013
2962013
Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial
F Meng, R Xu, S Wang, Z Xu, C Zhang, Y Li, T Yang, L Shi, J Fu, T Jiang, ...
Signal transduction and targeted therapy 5 (1), 172, 2020
2862020
Diagnosing Helicobacter pylori in vivo by confocal laser endoscopy
R Kiesslich, M Goetz, J Burg, M Stolte, E Siegel, MJ Maeurer, S Thomas, ...
Gastroenterology 128 (7), 2119-2123, 2005
2802005
Tuberculosis diagnostics and biomarkers: needs, challenges, recent advances, and opportunities
R McNerney, M Maeurer, I Abubakar, B Marais, TD Mchugh, N Ford, ...
Journal of Infectious Diseases 205 (suppl_2), S147-S158, 2012
2712012
Tuberculosis treatment and management—an update on treatment regimens, trials, new drugs, and adjunct therapies
A Zumla, J Chakaya, R Centis, L D'Ambrosio, P Mwaba, M Bates, ...
The Lancet Respiratory Medicine 3 (3), 220-234, 2015
2632015
Mass spectrometric identification of a naturally processed melanoma peptide recognized by CD8+ cytotoxic T lymphocytes.
C Castelli, WJ Storkus, MJ Maeurer, DM Martin, EC Huang, BN Pramanik, ...
The Journal of experimental medicine 181 (1), 363-368, 1995
2581995
Progress in tuberculosis vaccine development and host-directed therapies—a state of the art review
SHE Kaufmann, C Lange, M Rao, KN Balaji, M Lotze, M Schito, AI Zumla, ...
The lancet Respiratory medicine 2 (4), 301-320, 2014
2542014
The system can't perform the operation now. Try again later.
Articles 1–20